Evidence map›Paper›PMID 18591235›Full record

ArticleInfection and immunity2008

Pmp-like proteins Pls1 and Pls2 are secreted into the lumen of the Chlamydia trachomatis inclusion.

Ine Jorgensen, Raphael H Valdivia

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 46 citations in OpenAlex.

  1. Genome-wide association studies ofInfection and immunity · 2026
    Article
  2. Article
  3. Molecular pathogenesis ofFrontiers in cellular and infection microbiology · 2023
    Review
  4. Plasmid-mediated virulence inFrontiers in cellular and infection microbiology · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. The multiple functions of the numerousMicrobial cell (Graz, Austria) · 2019
    Review
  9. Article
  10. Article
  11. Article
  12. Following the Footsteps of Chlamydial Gene Regulation.Molecular biology and evolution · 2015
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Ine JorgensenDepartment of Molecular Genetics and Microbiology, Center for Microbial Pathogenesis, Duke University Medical Center, Durham, North Carolina 27710, USA.
Raphael H Valdivia
Duke Medical Center · USDuke University Hospital · US

Funding

Chlamydia Effector ProteinsR01AI081694 · NIAID · DUKE UNIVERSITY · PI VALDIVIA, RAPHAEL H · 2010 to 2014
$1.9M
Functional Genomic Analysis of the Chlamydia InclusionR21AI061538 · NIAID · DUKE UNIVERSITY · PI VALDIVIA, RAPHAEL H. · 2004 to 2005
$424k
NIAID NIH HHS AI061538NIAID NIH HHS R01 AI081694NIAID NIH HHS R21 AI061538
6 · The paper itself

Abstract

The obligate intracellular pathogen Chlamydia trachomatis secretes effector proteins across the membrane of the pathogen-containing vacuole (inclusion) to modulate host cellular functions. In an immunological screen for secreted chlamydial proteins, we identified CT049 and CT050 as potential inclusion membrane-associated proteins. These acidic, nonglobular proteins are paralogously related to the passenger domain of the polymorphic membrane protein PmpC and, like other Pmp proteins, are highly polymorphic among C. trachomatis ocular and urogenital strains. We generated antibodies to these Pmp-like secreted (Pls) proteins and determined by immunofluorescence microscopy that Pls1 (CT049) and Pls2 (CT050) localized to globular structures within the inclusion lumen and at the inclusion membrane. Fractionation of membranes and cytoplasmic components from infected cells by differential and density gradient centrifugation further indicated that Pls1 and Pls2 associated with membranes distinct from the bulk of bacterial and inclusion membranes. The accumulation of Pls1 and, to a lesser extent, Pls2 in the inclusion lumen was insensitive to the type III secretion inhibitor C1, suggesting that this translocation system is not essential for Pls protein secretion. In contrast, Pls secretion and stability were sensitive to low levels of beta-lactam antibiotics, suggesting that a functional cell wall is required for Pls secretion from the bacterial cell. Finally, we tested the requirement for these proteins in Chlamydia infection by microinjecting anti-Pls1 and anti-Pls2 antibodies into infected cells. Coinjection of anti-Pls1 and -Pls2 antibodies partially inhibited expansion of the inclusion. Because Pls proteins lack classical sec-dependent secretion signals, we propose that Pls proteins are secreted into the inclusion lumen by a novel mechanism to regulate events important for chlamydial replication and inclusion expansion.

Indexed as

Bacterial ProteinsCell FractionationCell MembraneCentrifugationCentrifugation, Density GradientChlamydia trachomatisGene OrderHeLa CellsHumansInclusion BodiesMembrane ProteinsMicroscopy, FluorescenceVirulence FactorsBacterial ProteinsMembrane ProteinsVirulence Factors

Identifiers

PMID18591235
PMCPMC2519427
OpenAlexW2134385421

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.